00
Days
00
Hours
00
Minutes
00
Seconds
| TIME | EVENT | SPEAKER |
|---|---|---|
| Moderators: D. Iancu M. Kelly J. Ospel and S. Peschillo | ||
| 07:30 - 08:00 | Welcome Coffee / Tea - Princes' Ballroom, 3rd floor | |
| 08:00 - 08:20 | Pictorial review of cSDH & meningioma angioarchitecture: implications for embolization | R. Kumar (Patna, India)  |
| 08:24 - 08:44 | Evidence of prospective trials on MMAE for cSDH: opportunities and challenges - will stand-alone MMAE become standard of care? | J.J. Shankar (Winnipeg, MB) |
| 08:46 - 09:06 | cSDH MMAE: Is one agent superior to others? Can we combine MMAE and SDH drainage into one procedure in the angiosuite? | P. Lylyk (Buenos Aires, Argentina) |
| 09:08 - 09:28 | New generation of magnetically steerable robotic “nanocatheters” and arcuable microwires | P. Mosimann (Toronto Western Hospital, ON) |
| 09:30 - 09:45 | Round Table discussion / Q&A | |
| 09:45 - 10:20 | Coffee Break & Industry Booth Visits - Princes' Ballroom, 3rd floor | |
| Next Moderators: B. Van Adel, R. Fahed and C. Parra-Farinas | ||
| 10:25 - 10:40 | 3D-printed and placenta models: defining the metrics to capture intuition-based practices and improve lifelong learning and teaching of INR techniques (including liquid embolics) | S. Peschillo (Link Campus University, Rome) |
| 10:42 - 11:27 | KEYNOTE LECTURE part 1: How brain and spine AVMs form, mature and involute | G. Rodesch (Suresnes Hospital & Rothschild foundation, Paris, France) |
| 11:28 - 11:58 | KEYNOTE LECTURE part 2: Underlying molecular and pharmacological targets | I. Radovanovic (Toronto Western Hospital, ON) |
| 12:00 - 13:10 | Lunch - Princes Ballroom, 3rd floor | |
| Next Moderators: B. van Adel, D.Tampieri, J. Raymond, F. Arnberg and I. Radovanovic | ||
| 13:12 - 13:37 | What is an AVM “nidus”? Concept of venous segmentation and therapeutic considerations | R. Chapot (Alfried Krupp Krankenhaus, Essen, Germany) |
| 13:37 - 13:50 | Ahead of the curve: the art and science of wire and microcatheter “shapeology” to increase the chances of successful arterial and venous navigation | R. Chapot (Alfried Krupp Krankenhaus, Essen, Germany) |
| 13:52 - 14:12 | Obtura: the next generation game changer embolic agent for endovascular cure of AVMs and hypervascular tumors | J. Llibre (Hospital Universitario de Salamanca, Spain) |
| 14:14 - 14:34 | DSA and MR fusion: the key to single session combined TAE/TVE embocure? How easy is it to implement ? | F. Arnberg (Karolinska Institutet, Sweden) |
| 14:36 - 14:50 | Round Table discussion / Q&A | |
| 14:50 - 15:25 | Coffee Break & Industry Booth Visits - Princes' Ballroom, 3rd floor | |
| Next Moderators: F. Arnberg, J. Shankar, R. Chapot and T. Darsaut | ||
| 15:26 - 15:32 | Pragmatic care trials on AVMs: natural history and prospective treatment benefit:harm ratio (TOBAS and TATAM) | D. Roy (CHUM, Montreal, QC) |
| 15:33 - 15:39 | Transvenous Approach for the Treatment of Cerebral Arteriovenous Malformations | T. Darsaut (Edmonton, AB) |
| 15:42 - 15:57 | Most AVMs are surgical: which ones benefit from embolization / hybrid approach? | I. Radovanovic (Toronto Western Hospital, ON) |
| 15:59 - 16:25 | Should we treat unruptured AVMs? If yes, what is the role of combining embolization with Gamma knife Surgery? | B. Karlsson (Singapore) |
| 16:27 - 16:47 | Modern techniques and innovations for fetal and pediatric AV shunts | P. Muthusami (Hospital for Sick Children, Toronto, ON) |
| 16:49 - 17:00 | Round Table discussion / Q&A | |
| 17:00 - 17:15 | In vivo plaque imaging : a revolution? | J Rempel (Edmonton, AB) |
| 17:16 - 17:24 | Live annotation tool for safer endovascular procedures | F. Arnberg (Karolinska Institutet, Sweden) |
| 17:25 - 17:32 | PHIL embolic agent for AVM embolization: single center long-term results | Prem Rangi (Queensquare, London, UK) |
| 17:33 - 17:41 | Squid-12 low viscosity liquid embolic agent: why it's essential for transvenous AVM embolization | R. Chapot (Alfried Krupp Krankenhaus, Essen, Germany) |
| 17:42 - 17:50 | Drivewire deflectable 0.024-in wire for neurointerventions | J Rempel (Edmonton, AB) |
| 17:51 - 17:59 | LVO EVT with Cereglide: single center experience | Robert Fahed (Ottawa, ON) |
| 18:00 - 18:08 | Experience with PC400 and Access 25 | Manraj Heran (Vancouver, BC) |